According to FutureWise analysis the market for artificial heart lung machines in 2023 is US$ 0.29 billion, and is expected to reach US$ 0.39 billion by 2031 at a CAGR of 3.82%.
An artificial heart-lung machine, also known as a cardiopulmonary bypass (CPB) or oxygenator pump, is used in coronary artery bypass surgery, heart and lung transplants, and other cardiac surgeries. It temporarily performs the functions of the heart and lungs, allowing the surgeon to operate within a bloodless surgical field that is in motion. In these machines, blood is drawn into a chamber, where it is oxygenated and circulated throughout the entire body. With the help of these pumps, significant advancements have been made in the management of severe respiratory failure, as well as in the area of cardiothoracic surgery. Through a series of tubes connected to the patient, the machine is connected to the patient's heart and lungs, which are removed after the surgery when the heart and lungs are able to function normally. In recent years, there has been a significant increase in the number of open-heart surgeries, heart transplants, and lung surgeries performed around the world. It can primarily be attributed to the onset of various chronic diseases and the increased incidence of organ failure due to changes in the environment and lifestyle. Additionally, several developing nations are making efforts to provide improved healthcare facilities to their citizens, which are driving the demand for artificial heart-lung machines.
FutureWise Market Research has instantiated a report that provides an intricate analysis of Artificial Heart Lung Machines Market trends that shall affect the overall market growth. Furthermore, it includes detailed information on the graph of profitability, SWOT analysis, market share and regional proliferation of this business. Moreover, the report offers insights on the current stature of prominent market players in the competitive landscape analysis of this market.
According to the research study conducted by FutureWise research analysts, the Artificial Heart Lung Machines Market is anticipated to attain substantial growth by the end of the forecast period. The report explains that this business is predicted to register a noteworthy growth rate over the forecast period. This report provides crucial information pertaining to the total valuation that is presently held by this industry and it also lists the segmentation of the market along with the growth opportunities present across this business vertical.